AES-135
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-114483-50 mg |
| CAS # | 2361659-61-0 |
| Pricing | 50 mg, USD $2200.0 |
| Biological Activity | AES-135, a hydroxamic acid-based HDAC inhibitor, prolongs survival in an orthotopic mouse model of pancreatic cancer. AES-135 inhibits HDAC3, HDAC6, HDAC8, and HDAC11 with IC50s ranging from 190-1100 nM[1]. |
| Purity | 98.31% |
| MWt | 693.66 |
| Formula | C₃₃H₂₉F₆N₃O₅S |